191 related articles for article (PubMed ID: 19506904)
1. Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction.
Choudhary S; Wang HC
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1601-13. PubMed ID: 19506904
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells.
Choudhary S; Rathore K; Wang HC
J Cancer Res Clin Oncol; 2011 Mar; 137(3):471-80. PubMed ID: 20473523
[TBL] [Abstract][Full Text] [Related]
3. Proapoptotic ability of oncogenic H-Ras to facilitate apoptosis induced by histone deacetylase inhibitors in human cancer cells.
Choudhary S; Wang HC
Mol Cancer Ther; 2007 Mar; 6(3):1099-111. PubMed ID: 17363503
[TBL] [Abstract][Full Text] [Related]
4. Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells.
Choudhary S; Wang HC
J Cancer Res Clin Oncol; 2007 Oct; 133(10):725-39. PubMed ID: 17487507
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic H-Ras, FK228, and exogenous H2O2 cooperatively activated the ERK pathway in selective induction of human urinary bladder cancer J82 cell death.
Choudhary S; Wang KK; Wang HC
Mol Carcinog; 2011 Mar; 50(3):215-9. PubMed ID: 21344509
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells.
Doi S; Soda H; Oka M; Tsurutani J; Kitazaki T; Nakamura Y; Fukuda M; Yamada Y; Kamihira S; Kohno S
Mol Cancer Ther; 2004 Nov; 3(11):1397-402. PubMed ID: 15542778
[TBL] [Abstract][Full Text] [Related]
7. FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells.
Sato N; Ohta T; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2004 Mar; 24(3):679-85. PubMed ID: 14767553
[TBL] [Abstract][Full Text] [Related]
8. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
9. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
[TBL] [Abstract][Full Text] [Related]
10. FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death.
Choudhary S; Rathore K; Wang HC
Anticancer Drugs; 2010 Oct; 21(9):831-40. PubMed ID: 20700043
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of signaling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228.
Fecteau KA; Mei J; Wang HC
J Pharmacol Exp Ther; 2002 Mar; 300(3):890-9. PubMed ID: 11861795
[TBL] [Abstract][Full Text] [Related]
12. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.
Aron JL; Parthun MR; Marcucci G; Kitada S; Mone AP; Davis ME; Shen T; Murphy T; Wickham J; Kanakry C; Lucas DM; Reed JC; Grever MR; Byrd JC
Blood; 2003 Jul; 102(2):652-8. PubMed ID: 12649137
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
[TBL] [Abstract][Full Text] [Related]
14. Spiruchostatin A and B, novel histone deacetylase inhibitors, induce apoptosis through reactive oxygen species-mitochondria pathway in human lymphoma U937 cells.
Rehman MU; Jawaid P; Yoshihisa Y; Li P; Zhao QL; Narita K; Katoh T; Kondo T; Shimizu T
Chem Biol Interact; 2014 Sep; 221():24-34. PubMed ID: 25078973
[TBL] [Abstract][Full Text] [Related]
15. Taxol induces caspase-10-dependent apoptosis.
Park SJ; Wu CH; Gordon JD; Zhong X; Emami A; Safa AR
J Biol Chem; 2004 Dec; 279(49):51057-67. PubMed ID: 15452117
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells.
Rosato RR; Almenara JA; Dai Y; Grant S
Mol Cancer Ther; 2003 Dec; 2(12):1273-84. PubMed ID: 14707268
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of the ERK pathway in modulating apoptosis of Ras-transformed and non-transformed cells induced by anticancer agent FR901228.
Song P; Wei J; Wang HC
FEBS Lett; 2005 Jan; 579(1):90-4. PubMed ID: 15620695
[TBL] [Abstract][Full Text] [Related]
18. A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
Hsu SC; Yu CC; Yang JS; Lai KC; Wu SH; Lin JJ; Kuo JH; Yang ST; Huang CC; Kuo SC; Chung JG
Int J Oncol; 2012 Mar; 40(3):731-8. PubMed ID: 22021033
[TBL] [Abstract][Full Text] [Related]
19. Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells.
Choi EO; Park C; Hwang HJ; Hong SH; Kim GY; Cho EJ; Kim WJ; Choi YH
Int J Oncol; 2016 Sep; 49(3):1009-18. PubMed ID: 27571890
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
